NEW ORLEANS, Jan. 20, 2022 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of GeneDx, Inc. to Sema4 Holdings Corp. ("the Company") (NasdaqGS: SMFR). Under the terms of the proposed transaction, Sema4 will acquire GeneDx for a total upfront consideration of approximately $473 million, and a total aggregate consideration including potential milestones of approximately $623 million, based on the closing stock price of Sema4 as of January 14, 2022. KSF is seeking to determine whether the merger and the process that led to it are adequate and fair to the Company's shareholders.
If you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (email@example.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-smfr/ to learn more.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.
Kahn Swick & Foti, LLC
1100 Poydras St., Suite 3200
New Orleans, LA 70163
View original content to download multimedia:
SOURCE Kahn Swick & Foti, LLC